FDB (First Databank) vs InpharmD (2026)
Embedded content against a mediated service. FDB supplies the drug knowledge under most US prescribing systems, so its interaction and dose logic is what clinicians already see when a warning fires. It now offers that content as grounding for other companies' AI. Its MedProof MCP server, generally available since March 2026, lets outside agents query FDB drug knowledge, and its Script Agent queues spoken prescriptions as orders for clinician review. InpharmD answers the question a clinician actually asked, with a board certified drug information pharmacist reviewing each drafted answer before it goes back. They serve different moments. At the point of prescribing, the embedded content wins because it is already there. For a formulary question no database covers, InpharmD does the work.
- Drug knowledge embedded in the systems used by most US hospitals, practices and pharmacies.
- A published MCP server that lets other AI products query its drug knowledge instead of answering from training data.
- New agents framed conservatively, with prescriptions queued for clinician approval.
- A board certified drug information pharmacist reviews every answer before it reaches the clinician.
- A stated SOC 2 Type II environment, where FDB publishes no security certification.
- A free pilot with a 30 day calibration period, usually entered through the pharmacy and therapeutics committee.
This comparison is published by AI Health Index, an independent research platform that compares healthcare AI vendors objectively. FDB (First Databank) and InpharmD are each graded against the same capability taxonomy, from each vendor's own public materials and the regulatory record, under the AI Health Index verification standard. No vendor pays for placement, and no vendor has reviewed this page. How this evidence is graded
Plain facts
| Fact | FDB (First Databank) | InpharmD |
|---|---|---|
| Primary category | Medication Safety & Prescribing | Clinical Reference & Evidence |
| Headquarters | South San Francisco, California, United States | Atlanta, Georgia |
| Website | fdbhealth.com | inpharmd.com |
Side by Side
Select any grade to read the note behind it.
Product updates
The latest logged changes from each vendor, newest first, each linked to its source.
FDB (First Databank)
-
Product / capability
FDB commercially deployed FDB Script Agent, an AI prescribing tool that converts ambient patient encounter dialogue directly into structured prescriptions.
Source
Each vendor in one paragraph
Written to be quoted whole. Each paragraph opens the AI Health Index profile of the vendor: what the product is, who buys it and what it does.
FDB, formerly First Databank, supplies the drug knowledge that sits underneath most medication decisions made in the United States. Its databases are integrated into the systems used by most hospitals, physician practices and pharmacies, which means that when a prescribing system warns about an interaction, a dose ceiling or a contraindication, the content behind that warning is frequently this company's rather than the software vendor's.
Source: AI Health Index, September 2026
Drug information service delivered as software, from an Atlanta company operating since at least 2014. Cofounders Ashish Advani, a pharmacist and the chief executive, and Tulasee Rao Chintha, chief technology officer. The company's own framing is drug information pharmacists without adding full time staff: a health system's clinical pharmacists ask any question, at any time, and receive a custom literature search and answer, so they can practice at the top of their license.
Source: AI Health Index, September 2026
Questions buyers ask
How do FDB (First Databank) and InpharmD handle patient data?
For FDB (First Databank), the licensed databases themselves are delivered inside customers' systems. The agentic products change the exposure: MedProof MCP serves knowledge in patient specific context, so patient details reach FDB on each tailored query, and Script Agent processes spoken clinical conversation.
With InpharmD, the privacy policy (effective May 2026) tells users not to submit protected health information, financial information or other sensitive personal information about themselves or anyone else, and says that if protected health information is submitted inadvertently the company assumes no responsibility for its handling under HIPAA. The FAQ says the company does not take protected health information. From the AI Health Index, drawn from each vendor's own published materials and the regulatory record, verified September 29, 2026. No vendor pays for placement.
Which settings and specialties do FDB (First Databank) and InpharmD cover?
In FDB (First Databank)'s case, the newer products deliberately address both ends of the workflow, with prescription automation aimed at ambulatory practice and order verification aimed at inpatient pharmacy.
For InpharmD, the scope is drug information and formulary work for health systems: clinical pharmacists are the primary users, the terms extend use to qualified healthcare professionals, and the FAQ says the service is not yet available to patients. From the AI Health Index, drawn from each vendor's own published materials and the regulatory record, verified September 29, 2026. No vendor pays for placement.
What evidence is published for FDB (First Databank) and InpharmD?
With FDB (First Databank), the most notable absence is any comparison of whether agents grounded on FDB content give safer answers than agents that are not.
The home page and FAQ state that more than 30 health systems retain an InpharmD virtual drug information pharmacist, that the service is trusted by more than 20,000 clinical pharmacists, 161,050 clinical pharmacist hours saved, a return on investment of more than four times, and a 100 percent customer satisfaction rate. From the AI Health Index, drawn from each vendor's own published materials and the regulatory record, verified September 29, 2026. No vendor pays for placement.
Related comparisons
Other published head to head assessments involving these vendors or their closest peers. The full set for this category is on the Clinical Decision Support page.
Both records were reviewed on this site in September 2026. Neither publishes a price. FDB states it acts as a HIPAA business associate for its customers; InpharmD takes no patient information. Opening its content to outside AI agents makes FDB's missing security certification matter more.
Ask FDB how an MCP connection is secured and logged, and ask InpharmD for its turnaround time distribution.